Marketing norm perception among medical representatives in Indian pharmaceutical industry

Molugulu Nagashekhara1, Syed Omar Syed Agil2, Ravindran Ramasamy3

  • 1Masterskill College of Nursing and Health, KK Metro Branch, Kota Kinabalu, Sabah, Malaysia.

Insights

This study found that medical representatives' perceptions of marketing norms differ based on their employer (domestic vs. multinational) and educational background, but not gender. Training on marketing norms is recommended for better decision-making.

Area of Science:

  • Pharmaceutical Marketing
  • Medical Sales Ethics
  • Organizational Behavior

Background:

  • Marketing norm perception is crucial yet under-researched in the pharmaceutical sector.
  • Understanding these perceptions is vital for ethical sales practices and industry standards.

Purpose of the Study:

  • To investigate the perception of marketing norms among medical representatives.
  • To identify factors influencing these perceptions within the pharmaceutical industry.

Main Methods:

  • Quantitative, cross-sectional study design.
  • Data collected from 300 medical representatives using simple random and cluster sampling.
  • Structured questionnaire administered for data collection.

Main Results:

  • No significant difference in perception based on gender.
  • Significant differences observed between representatives from domestic and multinational companies.
  • Educational background impacts perception; degree holders and multinational company representatives show higher perception.

Conclusions:

  • Medical representatives' perceptions of marketing norms are influenced by company type and education, not gender.
  • Mandatory training on marketing norms is suggested to aid decision-making in sales-related dilemmas.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.3K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97